One Term Every Biotech Trader Should Know

I’ve made a career using an event-driven trading style… specifically something I call a catalyst runup strategy in biotech stocks. I’ve averaged over $1M in trading profits over the last four years—largely based on the strategy! The best part is…you don’t have...

The trade war can’t stop these stocks

Stocks still can’t seem to figure out whether they want to break out to new highs or revisit the summer lows… However, traders remain hypersensitive to news headlines—causing a lot of back and forth price action. During periods of uncertainty, I try to stay patient...

How to protect your trading account

It’s been a sloppy start to October… as geopolitical tensions steal headlines from an already jam-packed news-driven market.   There’s so much noise right now that it’s been hard to find great setups and follow through… even seasoned traders are finding it difficult. ...

How to protect your trading account

It’s been a sloppy start to October… as geopolitical tensions steal headlines from an already jam-packed news-driven market.   There’s so much noise right now that it’s been hard to find great setups and follow through… even seasoned traders are finding it difficult. ...

Run up on these stocks

When you think about trading biotech or pharmaceutical stocks… the first thing that pops into most people’s mind is, Johnson & Johnson, Merck & Co. or Novartis… Companies like Melinta Therapeutics and Chiasma are foreign to most casual traders.   However, if...